Humana Inc. (NYSE:HUM) declared a quarterly dividend on Thursday, November 2nd, RTT News reports. Shareholders of record on Friday, December 29th will be paid a dividend of 0.40 per share by the insurance provider on Friday, January 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.63%.
Humana has raised its dividend payment by an average of 3.1% per year over the last three years and has increased its dividend annually for the last 6 consecutive years. Humana has a dividend payout ratio of 13.8% meaning its dividend is sufficiently covered by earnings. Analysts expect Humana to earn $12.21 per share next year, which means the company should continue to be able to cover its $1.60 annual dividend with an expected future payout ratio of 13.1%.
Humana (NYSE:HUM) last posted its earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, topping analysts’ consensus estimates of $3.08 by $0.41. The firm had revenue of $13.53 billion for the quarter, compared to analysts’ expectations of $13.61 billion. Humana had a net margin of 3.37% and a return on equity of 15.85%. During the same quarter in the previous year, the firm posted $2.30 earnings per share.
In other Humana news, insider Elizabeth D. Bierbower sold 9,786 shares of the company’s stock in a transaction on Friday, September 1st. The shares were sold at an average price of $259.00, for a total transaction of $2,534,574.00. Following the sale, the insider now owns 18,042 shares of the company’s stock, valued at $4,672,878. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Bruce D. Broussard sold 12,000 shares of the company’s stock in a transaction on Friday, August 11th. The shares were sold at an average price of $251.88, for a total transaction of $3,022,560.00. Following the sale, the chief executive officer now directly owns 80,086 shares in the company, valued at approximately $20,172,061.68. The disclosure for this sale can be found here. Insiders have sold 55,595 shares of company stock worth $14,133,706 in the last ninety days. Insiders own 0.80% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This report was originally published by Community Financial News and is the property of of Community Financial News. If you are accessing this report on another website, it was copied illegally and republished in violation of U.S. and international copyright and trademark law. The original version of this report can be accessed at https://www.com-unik.info/2017/11/02/humana-inc-hum-to-issue-quarterly-dividend-of-0-40.html.
A number of analysts have weighed in on the stock. Credit Suisse Group AG reaffirmed an “outperform” rating and set a $260.00 target price (up previously from $250.00) on shares of Humana in a research note on Thursday, August 3rd. Deutsche Bank AG boosted their target price on shares of Humana from $234.00 to $243.00 and gave the stock a “hold” rating in a research note on Monday, August 7th. Oppenheimer Holdings, Inc. boosted their target price on shares of Humana from $236.00 to $255.00 and gave the stock an “outperform” rating in a research note on Thursday, August 3rd. BidaskClub cut shares of Humana from a “hold” rating to a “sell” rating in a research note on Thursday, August 17th. Finally, ValuEngine cut shares of Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Twelve research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Humana presently has an average rating of “Buy” and an average price target of $253.90.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
What are top analysts saying about Humana Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Humana Inc. and related companies.